Literature DB >> 27940966

Statins for primary prevention of cardiovascular disease : Patients need better tools to navigate divergent recommendations.

Catherine M Otto.   

Abstract

Entities:  

Keywords:  CARDIAC PROCEDURES AND THERAPY

Mesh：

Substances：

Year:  2016        PMID： 27940966     DOI： 10.1136/heartjnl-2016-310959

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

Review 1.  The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis.

Authors:  Michael Garshick; James A Underberg
Journal:  Curr Atheroscler Rep       Date:  2017-10-17       Impact factor: 5.113

2.  FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation.

Authors:  James M Murphy; Kyuho Jeong; Yelitza A R Rodriguez; Jung-Hyun Kim; Eun-Young Erin Ahn; Ssang-Taek Steve Lim
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

3.  Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts.

Authors:  Henock G Yebyo; Hélène E Aschmann; Tsung Yu; Milo A Puhan
Journal:  BMC Cardiovasc Disord       Date:  2018-05-18       Impact factor: 2.298

4.  Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study.

Authors:  Joseph C Engeda; Stefan K Lhachimi; Wayne D Rosamond; Jennifer L Lund; Thomas C Keyserling; Monika M Safford; Lisandro D Colantonio; Paul Muntner; Christy L Avery
Journal:  PLoS Med       Date:  2020-08-26       Impact factor: 11.069
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.